However, no significant correlation of genotype distributions of ABCG2 G34A, C421A polymorphisms was observed with other clinicopathological parameters (age at diagnosis, menopausal status, first-degree family history of cancer, tumor size, histology, lymph node metastasis, HER2 status, p53 status, BRCA1 status, and BRCA2 status). This evidence concerns the gene TP53 and metastatic malignant neoplasm in the lymph nodes.